Clinical trial Recruiting at 1 site Observational Ages 18 to 100

Registry of patients treated with transcatheter aortic valve implantation

Official title: A Prospective Follow-up Assessment of Transcatheter Aortic Valve Implantation in Bad Segeberg

Run by Segeberger Kliniken GmbH · NCT03192774 · Data updated 2026-11-12

This study is tracking the health and recovery of patients who receive a new heart valve through a minimally invasive procedure to see how well it works over time.

More Aortic Valve Stenosis trials

Quick facts

Study typeObservational
Ages18 Years to 100 Years
SexAll
Enrollment2000 (estimated)
SponsorSegeberger Kliniken GmbH
Academic / other
Locations1 site (Bad Segeberg)
StatusRecruiting
StartedSeptember 2007
Main results expectedDecember 2022
Study endsDecember 2032
Registry record updatedJune 6, 2022
Trial IDNCT03192774 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this registry are all patients who are treated with TAVI at the Heart Center.

Probably not a fit

Patients who do not undergo TAVI or are treated at other facilities may not benefit from this registry.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry collects data from all patients who undergo transcatheter aortic valve implantation (TAVI) at the Heart Center in Bad Segeberg, Germany. It aims to monitor patient outcomes through routine clinical and echocardiographic follow-ups, extending beyond five years to evaluate the durability of the implanted valves. The study is observational, meaning it will gather data without altering the standard treatment protocols for these patients.

Why it matters

Potential benefit: If successful, this registry could provide valuable insights into the long-term effectiveness and safety of TAVI, ultimately improving patient care.

How similar studies have gone: Other registries and studies on TAVI have shown success in improving patient outcomes and understanding valve durability, indicating that this approach is supported by previous findings.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All patients treated with TAVI

Exclusion Criteria:

* None

Where it's running

  • Heart Center, Segeberger Kliniken
    Bad Segeberg, Germany
    Recruiting

Study contacts

  • Principal investigator: Mohamed Abdel-Wahab, MD — Heart Center, Segeberger Kliniken
  • Study coordinator: Mohamed Abdel-Wahab, MD
  • Email: msabdelwahab@gmail.com

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.